{"acquisitions":[],"changes":[{"companyHref":"/c/scorpiontx-com","date":"2026-10-03","documentUrl":"https://atlasventure.com/portfolio/","domain":"scorpiontx.com","fact":"provenance:existence","name":"Scorpion Therapeutics","new":{"publisher":"Atlas Venture","status":"sourced","url":"https://atlasventure.com/portfolio/"},"old":{"publisher":"scorpiontx.com","status":"self-reported","url":"https://scorpiontx.com"},"publisher":"Atlas Venture","reason":null,"retrievedAt":"2026-10-03","slug":"scorpiontx-com","status":"sourced","url":"https://whoraisedwhat.com/c/scorpiontx-com"},{"companyHref":"/c/scorpiontx-com","date":"2026-09-30","documentUrl":"https://atlasventure.com/portfolio/","domain":"scorpiontx.com","fact":"provenance:investor:atlas-venture","name":"Scorpion Therapeutics","new":{"publisher":"Atlas Venture","status":"sourced","url":"https://atlasventure.com/portfolio/"},"old":{"publisher":null,"status":"unknown","url":null},"publisher":"Atlas Venture","reason":null,"retrievedAt":"2026-09-30","slug":"scorpiontx-com","status":"sourced","url":"https://whoraisedwhat.com/c/scorpiontx-com"},{"companyHref":"/c/scorpiontx-com","date":"2026-09-27","documentUrl":null,"domain":"scorpiontx.com","fact":"latest round","name":"Scorpion Therapeutics","new":{"amountUsd":150000000,"date":"2024-07-01","lead":null,"type":"series-c"},"old":{"amountUsd":150000000,"date":"2024-07-01","lead":"lightspeed","type":"series-c"},"publisher":"crunchbase","reason":null,"retrievedAt":"2026-05-07","slug":"scorpiontx-com","status":"attributed","url":"https://whoraisedwhat.com/c/scorpiontx-com"}],"country":"US","description":"Scorpion Therapeutics is a clinical-stage precision-oncology biotech designing mutant-selective small molecules for patients with specific cancer driver mutations. It targets PI3K-alpha-mutant breast, gynecological, and other solid tumors. Lilly acquired the lead program STX-478 for up to $2.5B in milestones in early 2025.","domain":"scorpiontx.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":["lightspeed","atlas-venture"],"lat":42.358834,"lng":-71.05783,"location":"Boston MA","multiples":[],"name":"Scorpion Therapeutics","nameSource":{"publisher":"Atlas Venture","retrievedAt":"2026-10-03","status":"sourced","url":"https://atlasventure.com/portfolio/"},"people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":150000000,"connectionsAmong":[],"currency":"USD","date":"2024-07-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"scorpiontx-com-2024-07-01-series-c","source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"series-c","url":null}],"slug":"scorpiontx-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"Atlas Venture","retrievedAt":"2026-10-03","status":"sourced","url":"https://atlasventure.com/portfolio/"},{"fact":"description","publisher":"scorpiontx.com","retrievedAt":"2026-10-03","status":"self-reported","url":"https://scorpiontx.com"},{"fact":"investor:atlas-venture","publisher":"Atlas Venture","retrievedAt":"2026-09-30","status":"sourced","url":"https://atlasventure.com/portfolio/"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[{"id":"investor:{\"actorKind\": \"investor\", \"name\": \"Atlas Venture\", \"role\": \"portfolio\", \"slug\": \"atlas-venture\", \"sources\": [{\"publisher\": \"Atlas Venture\", \"retrievedAt\": \"2026-09-30\", \"status\": \"sourced\", \"url\": \"https://atlasventure.com/portfolio/\"}]}","kind":"investor","sources":[{"publisher":"Atlas Venture","retrievedAt":"2026-09-30","status":"sourced","url":"https://atlasventure.com/portfolio/"}],"text":"Scorpion Therapeutics was listed in Atlas Venture's portfolio, recorded 2026-09-30."}],"generatedAt":"2026-11-09","investors":[{"actorKind":"investor","name":"Atlas Venture","role":"portfolio","slug":"atlas-venture","sources":[{"publisher":"Atlas Venture","retrievedAt":"2026-09-30","status":"sourced","url":"https://atlasventure.com/portfolio/"}]}],"state":"insufficient-evidence","tldr":[]},"techStack":[],"totalRaisedUsd":150000000,"traction":[],"updatedAt":"2026-10-03","valuations":[]}